Advertisement
Advertisement

IMMP

IMMP logo

Immutep Limited - ADR

2.07
USD
-0.05
-2.36%
Dec 20, 15:59 UTC -5
Closed
...

Immutep Limited - ADR Profile

About

Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.

Info & Links

CEO

Marc Voigt

Headquarters

LEVEL 33, 264 GEORGE STREET
SYDNEY, C3 2000, AUSTRALIA

Auditor

PricewaterhouseCoopers

Share holders

13,153

Employees

35

Immutep Limited - ADR Statistics

Valuation Measures

Market Capitalization2

301.10M

Enterprise Value

195.63M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.03

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

2.22

52-Week Change

0.49%

S&P 500 52-Week Change

24.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

140.99M

% Held by Insiders

3.07%

% Held by Institutions

2.32%

Balance Sheet

Total Cash(mrq)

--

Total Cash Per Share(mrq)

--

Total Debt(mrq)

--

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

18.25%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement